Abstract:Aims: Hydroxychloroquine (HCQ) has a high variability and a long half-life in the human body. The purpose of this study was to evaluate the bioequivalence of a generic HCQ tablet (test preparation) versus a brand HCQ tablet (reference preparation) under fasting and fed conditions in a crossover design. Materials and methods: This was an open-label, two-period randomized, single-dose, crossover study in 47 healthy Chinese subjects who were sequentially and randomly allocated either to the fed group (high-fat meal; n = 23) or the fasting group (n = 24). Participants in each group were randomized to the two arms to receive either a single 200-mg dose of the test preparation or a 200-mg dose of the reference preparation. The application of the two preparations in each patient was separated by a 28-day washout period, regarded as sufficiently long to avoid significant interference from residual drug in the body. Whole blood samples were collected over 72 hours after drug administration. Results: A total of 23 subjects completed both the fed and the fasting parts of the trial. There were no significant differences in Cmax, AUC0-72h, and T1/2 between the test and reference preparation (p < 0.05). Food had no significant effect on Cmax and T1/2 (p < 0.05), but AUC0-72h values were significantly reduced under fed condition compared to fasting condition (p < 0.05). The 90% confidence intervals (CIs) for the geometric mean ratios (GMRs) of Cmax and AUC0-72h were 0.84 - 1.05 and 0.89 - 0.98 in the fed study, and 0.97 - 1.07 and 0.97 - 1.05 in the fasting study, respectively. The carryover effect due to non-zero blood concentrations resulted in higher AUC0-72h values in the second period for both test and reference formulations and had no effect on the statistical results. No serious adverse events were reported. Conclusion: The investigation demonstrated that the test and reference preparations are bioequivalent and well tolerated under both fasting and fed conditions in healthy Chinese subjects.

The relative bioavailability of allopurinol tablets in man

Pharmacokinetics And Relative Bioavailability Of Two Allopurinol Tablets In Healthy Chinese Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

The bioequivalence of oxaprozin enteric tablet in healthy volunteers measured with HPLC

Pharmacokinetics and Bioequivalance of Ibuprofen Tablet in Healthy Volunteers

Relative bioavailability and bioequivalence of clopidogrel hydrogen sulfate tablets in healthy volunteers

A Study of the Bioequivalence of Fleroxacin Tablets in Healthy Chinese Volunteers

Determination of Allopurinol in Human Plasma by HPLC

Study on relative bioavailability of acyclovir tablets in healthy volunteers

Study on bioequivalence of pravastatin sodium tablets in healthy volunteers

Relative bioavailability of mycophenolate mofetil capsules in healthy volunteers

Relative bioavailability and bioequivalence of ibuprofen orally disintegrating tablets in healthy volunteers

Relative bioavailability of cefpodoxime proxetil tablets in healthy volunteers

A crossover study to evaluate the pharmacokinetics and bioequivalence of hydroxychloroquine tablets in healthy Chinese subjects

Relative Bioavailability and Bioequivalence of Famciclovir Tablets in Healthy Volunteers

Bioequivalence of high variation drug abiraterone acetate tablets in healthy subjects

Pharmacokinetics and relative bioavailability of clarithromycin tablet in human

Study of the Bioequivalence of Isopropiram Fumarate Tablets in Healthy Volunteers

Study on bioequivalence and pharmacokinetics of compound glycyrrhizin capsules in healthy volunteers

Pharmacokinetics and Bioequivalance of Clarithromycin Dispersed Tablet in Healthy Volunteers